Put a price on research breakthroughs
Summary
The article argues for a funding model to accelerate AI research by separating research from product development, using pre-registered acquisitions or pull funding to ensure researchers can pursue breakthroughs without chasing immediate revenue. It draws a pharma-inspired analogy for risk sharing between frontier labs, neolabs, and investors, and proposes open offers or private options to commit to outcomes, reducing uncertainty and aligning incentives.